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Abstract
Notch signalling is a fundamental pathway that shapes the developing embryo and sustains
adult tissues by direct communication between ligand and receptor molecules on adjacent
cells. Among the ligands are two Delta paralogues, DLL1 and DLL4, that are conserved in
mammals and share a similar structure and sequence. They activate the Notch receptor
partly in overlapping expression domains where they fulfil redundant functions in some pro-
cesses (e.g. maintenance of the crypt cell progenitor pool). In other processes, however,
they appear to act differently (e.g. maintenance of foetal arterial identity) raising the ques-
tions of how similar DLL1 and DLL4 really are and which mechanism causes the apparent
context-dependent divergence. By analysing mice that conditionally overexpress DLL1 or
DLL4 from the same genomic locus (Hprt) and mice that express DLL4 instead of DLL1
from the endogenous Dll1 locus (Dll1Dll4ki), we found functional differences that are
tissue-specific: while DLL1 and DLL4 act redundantly during the maintenance of retinal pro-
genitors, their function varies in the presomitic mesoderm (PSM) where somites form in a
Notch-dependent process. In the anterior PSM, every cell expresses both Notch receptors
and ligands, and DLL1 is the only activator of Notch while DLL4 is not endogenously
expressed. Transgenic DLL4 cannot replace DLL1 during somitogenesis and in heterozy-
gous Dll1Dll4ki/+mice, the Dll1Dll4ki allele causes a dominant segmentation phenotype. Test-
ing several aspects of the complex Notch signalling system in vitro, we found that both
ligands have a similar trans-activation potential but that only DLL4 is an efficient cis-inhibitor
of Notch signalling, causing a reduced net activation of Notch. These differential cis-inhibi-
tory properties are likely to contribute to the functional divergence of DLL1 and DLL4.
Author Summary
Notch signalling relies on binding of a ligand to a Notch receptor, both residing on the sur-
faces of neighbouring cells. This interaction forwards a signal into the receptor-expressing
cell, this way coordinating cells in many biological processes such as the segmentation of
the axial skeleton. Mammals possess four Notch-activating ligands–including DLL1 and
DLL4 -expressed in diverse, partially overlapping regions. Whether the different ligands
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trigger quantitatively or qualitatively distinct Notch responses is largely unknown. In
order to directly compare both ligands we generated transgenic mice that express DLL1 or
DLL4 in identical patterns. These mice uncover that only DLL1 but not DLL4 can mediate
regular segmentation of the embryo. In experiments with cultured cells expressing either
ligand and Notch, we found that the functional difference observed is unlikely to depend
on differences in the activation of Notch. Rather, the unsuspected but strong difference
between both ligands in cis-inhibition, i.e. repression of Notch by a ligand expressed in the
same cell as the receptor, a process described in the fruitfly but not in mammals and not
for DLL4 provides a possible explanation for the divergence in tissues that coexpress
ligand and receptor.
Introduction
The Notch signalling pathway mediates local interactions between adjacent cells and thereby
regulates numerous developmental processes in a wide variety of different tissues throughout
the animal kingdom [reviewed in 1–7]. The Notch gene of Drosophila and its vertebrate homo-
logues encode large transmembrane proteins that act as receptors at the surface of the cell.
They interact with transmembrane ligand proteins on the surface of neighbouring, signal-send-
ing cells (i.e. in trans) encoded by the Delta and Serrate (called Jagged in vertebrates) genes.
Upon ligand binding, the intracellular domain of Notch (NICD) is proteolytically released,
translocates to the nucleus, interacts with the transcriptional regulator Suppressor of Hairless
([Su(H)]; CSL proteins in vertebrates) and activates the transcription of downstream target
genes [8–14]. Ligands coexpressed with the Notch receptor in signal-receiving cells (i.e. in cis)
are capable of interacting with Notch and attenuate the signal strength [15–17, reviewed in 18].
Vertebrates possess several Notch receptors and ligands. The mouse genome encodes four
Notch (NOTCH1–4), three Delta (DLL1, DLL3 and DLL4) and two Jagged (JAG1 and JAG2)
proteins. Among the DLL proteins, only DLL1 and DLL4 function as Notch-activating ligands
[19–21]. As paralogues, DLL1 and DLL4 are similar in sequence (47% identical plus 14% simi-
lar amino acids), size and domain structure [22]. Both contain a DSL domain, which is essential
for the interaction with Notch [23,24], as well as eight EGF-like repeats in their extracellular
domain and have a short intracellular domain with a C-terminal PDZ binding motif. Dll1 and
Dll4 are expressed both in discrete and overlapping patterns during embryonic development
and in adult tissues of the mouse. In shared expression domains, the two ligands have redun-
dant or different functions depending on the developmental context. An example for full
redundancy is the maintenance of the crypt progenitor pool in the adult small intestine. Dll1
and Dll4 are coexpressed in crypt cells [25,26] and individual inactivation of either ligand has
no effect on the crypt progenitor cell pool. However, simultaneous deletion of Dll1 and Dll4
leads to a complete loss of the proliferative crypt compartment and intestinal stem cells [27].
Conversely, in foetal arteries where both ligands are expressed in the vascular endothelium
[26,28,29] inactivation of Dll1 causes loss of NOTCH1 activation despite the presence of DLL4
[29] suggesting that DLL4 cannot compensate for the loss of DLL1 in fetal endothelial cells. In
the adult thymus, Dll1 and Dll4 are both expressed in thymic epithelial cells [26,30]. Here,
DLL4 is the essential Notch ligand required for T-lymphopoiesis [31] and T cell development
is unaltered in mice lacking DLL1 in the thymic epithelium [32] suggesting that in this context
DLL1 and DLL4 are functionally distinct. This conclusion is supported by in vitro studies
showing that DLL1 and DLL4 differ with respect to their binding avidity to Notch receptors on
thymocytes and to the steady-state cell surface levels required to induce T cell development,
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DLL4 being the more effective ligand [33,34] as well as by biochemical studies indicating a
10-fold higher Notch binding affinity of DLL4 than DLL1 [19]. Furthermore, DLL4 but not
DLL1 can induce a fate switch in skeletal myoblasts and induce pericyte markers [35]. Collec-
tively, these individual reports of context-dependent redundant and distinct functions of coex-
pressed DLL1 and DLL4 raise the questions of why DLL1 and DLL4 act equally in some
processes but differently in others, which mechanism or factor causes their function to vary
and whether they are similar enough to replace each other in domains where only one of both
DLL ligands is endogenously expressed.
In early mouse embryos, expression of Dll1 and Dll4 is largely non-overlapping. Dll1 is
expressed in the paraxial mesoderm beginning at E7.5, in the central nervous system from E9
onwards and later on, at E13.5, in arterial endothelial cells [29,36]. Deletion of Dll1 disrupts
somite patterning and causes premature myogenic differentiation, severe haemorrhages and
embryonic death after E11 [37,38]. Dll4 is expressed in the vascular endothelium of arteries
beginning at E8 [39] but not in the somite-generating presomitic mesoderm, somites or
differentiating myoblasts. Inactivation of DLL4 results in severe vascular defects leading to
embryonic death prior to E10.5 [39,40].
Here, we address the functional equivalence of DLL1 and DLL4 in vivo and in vitro. We ana-
lyse Notch signalling in mice that conditionally overexpress DLL1 or DLL4 on a Dll1 null
genetic background and in mice in which Dll1 is replaced by Dll4, focussing on young embryos
in which both Notch ligands have discrete endogenous expression domains. We show that
DLL4 cannot replace DLL1 during somite segmentation but can partially replace DLL1 during
myogenesis and fully replace DLL1 during maintenance of retinal progenitors. Cell culture
assays that measure Notch activation by DLL1 or DLL4 demonstrate that DLL4 trans-activates
Notch signalling similarly to DLL1 but cis-inhibits Notch signalling much more efficiently
than DLL1, partly overruling the activation by interactions in trans. Consistent with these in
vitro data, we observe dominant effects on segmentation by DLL4 ectopically expressed in the
presomitic mesoderm (PSM). We propose that differential Notch cis-inhibition by DLL1 and
DLL4 contributes to the observed tissue-dependent functional divergence of both paralogues,
perhaps in combination with other factors not tested in this study.
Results
Mesodermal expression of DLL1 but not DLL4 rescues the Dll1 knock-
out somitogenesis phenotype
In order to directly compare the activities of DLL1 and DLL4 in vivo, we generated mice that
conditionally express either Dll1 or Dll4 under the CAG promoter from a single-copy trans-
gene insertion in the same genomic locus. We employed an established system for integration
of Cre-inducible expression constructs into theHprt locus, the pMP8.CAG-Stop vector (Fig
1A; [41,42]). The unrecombined pMP8.CAG-Stop construct expresses neomycin phospho-
transferase (neor) from the CAG promoter. Cre-mediated recombination of two loxP sites and
two mutant loxP2272 (loxM) sites [43] flips the gene of interest and excises neor so that the
recombined construct expresses the gene of interest from the CAG promoter. 5’ and 3’ homol-
ogy regions from the Hprt gene enable homologous recombination of pMP8 constructs into
theHprt locus [44]. We cloned the Dll1 and Dll4 open reading frames into the pMP8.CAG-
Stop vector, introduced both unrecombined (i.e. neor expressing) constructs into Hprt-defi-
cient E14TG2a ES cells and used homologous recombinant clones to produce transgenic mice
with Cre-inducible Dll1 or Dll4 (alleles termed CAG:Dll1 and CAG:Dll4).
To check activation of DLL1 and DLL4 in embryos, we induced ubiquitous expression of
the CAG:Dll1 and CAG:Dll4 transgene by mating our mice with mice carrying a ZP3:Cre
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transgene that causes site-specific recombination during oogenesis [45]. We crossed CAG:Dll1;
ZP3:Cre and CAG:Dll4;ZP3:Cre females with wildtype males to obtain embryos that overex-
press Dll1 or Dll4 from the zygote stage on. The transgenes are transcribed bicistronically
with an IRES-Venus (Fig 1A) whose expression marks cells in which Cre-recombination acti-
vated the transgene. As Hprt is located on the X chromosome, hemizygous male embryos
expressed Venus ubiquitously whereas heterozygous female embryos showed mosaic expres-
sion due to random X-inactivation (Fig 1B). Analysis of embryo lysates on a Western blot
with anti-GFP antibodies demonstrated CAG:Dll1 and -4 transgene activation at similar levels
Fig 1. Mesodermally expressed CAG:DLL1 but not CAG:DLL4 functionally replaces endogenous DLL1 during somitogenesis. (A) Structure of
unrecombined and recombined (bottom) pMP8.CAG-Stop/Dll vector for integration of Cre-inducible expression constructs into the Hprt locus. 5‘hom and
3‘hom, 5’ and 3’ homology regions from theHprt gene for homologous recombination; ex (grey boxes),HPRT exons;CAG prom, CAG promoter to drive
transgene expression; neor, neomycin phosphotransferase; pA, polyadenylation signal; Dll1/4–Venus, Dll1 or Dll4ORF–joined to the reporter gene Venus by
an internal ribosomal entry site (IRES); hHPRT prom, humanHPRT promoter; light/dark grey triangles, loxP/loxM sites (in “flip excision” orientation); “Cre”
arrow, Cre-mediated recombination. (B) Venus reporter expression in E8.5CAG:Dll1 andCAG:Dll4 embryos indicated ubiquitous transgene activation after
ZP3:Cre-mediated recombination. As expected, overall fluorescence in female embryos (a,c) was weaker than in male embryos (b,d) due to random X-
chromosome inactivation. Numbers of embryos analysed are given in bottom right corner. (C)Quantification of Venus protein (CAG:Dll1 set to one) by
Western blot analysis of embryo lysates with anti-GFP antibodies (and anti-β-actin antibodies for normalisation) showed similar expression levels. (D) For
direct comparison of DLL protein levels, we also integrated single copies of Dll1 and Dll4 labelled with C-terminal HA-tags following the strategy in (A) using
recombined (active) constructs for electroporation of embryonic stem (ES) cells. Western blot analysis of three ES cell clones expressing either of these
transgenes using anti-HA antibodies confirmed similar expression levels with expected mild clonal variations (a); means of all three CAG:Dll1-HA and all
three CAG:Dll4-HA clones are shown in (b). (E) Cranial-caudal somite patterning visualised by whole mount in situ hybridisation of E9.5 embryos with an
Uncx4.1 probe showed an extensive rescue of somitogenesis plus ectopic Notch activation by CAG:DLL1 (b,c) but no appreciable rescue of somitogenesis
by CAG:DLL4 (e,f). Insets in Ea-c and Ee-g show higher magnifications of the regions as indicated. Error bars represent standard error of the mean (SEM);
ns, not significant; *, P<0.05; **, P<0.01.
doi:10.1371/journal.pgen.1005328.g001
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(Fig 1C; S1A Fig; S1 Table). To directly compare DLL1 and DLL4 protein levels, we generated
embryonic stem cells expressing HA-tagged Dll1 or Dll4 from single copy insertions of in the
Hprt locus. Western blot analysis of three independent clones for each ligand confirmed similar
protein levels in all clones (average DLL1-HA, 1.23±0.33; average DLL4-HA, 0.88±0.53; Fig
1D; S1B Fig; S2 Table).
In order to test whether DLL4 can compensate for the loss of DLL1 in mesodermal tissues
of early embryos, we mated mice to combine three different transgenes: a) CAG:Dll1 or -4
inducible transgenes; b) two (i.e. homozygous) floxed alleles of endogenous Dll1 [Dll1loxP/
loxP; 32] that get inactive upon recombination; and c) a Cre transgene expressed in the primi-
tive streak driven by a promoter derived from brachyury [T(s):Cre; 46]. In offspring bearing
the complete set of transgenes (identified by genotyping PCR; see Material and Methods),
recombination by T(s):Cre simultaneously inactivates endogenous Dll1 and activates CAG:
DLL1 or CAG:DLL4 expression in all mesoderm-derived tissues.
As expected, inactivation of Dll1 throughout the mesoderm resulted in severe somite pat-
terning defects characterised by loss of Uncx4.1 expression (Fig 1Ed), a marker for caudal
somite compartments [47,48] whose expression depends on Notch activation [46]. Expression
of CAG:DLL1 in such Dll1-deficient embryos restored robust, largely regularly striped expres-
sion of Uncx4.1, which expanded into cranial somite compartments in most axial regions and
particularly in hemizygous male embryos (Fig 1Eb and 1Ec). This rescue of somitogenesis dem-
onstrates that expression of CAG:DLL1 (from theHprt locus) is sufficient to substitute for the
loss of endogenous DLL1; cranial expansion of Uncx4.1 is reminiscent of ectopic Notch activity
[46].
In contrast, expression of CAG:DLL4 in Dll1-deficient embryos restored only very weak
and irregular expression of Uncx4.1 and resembles Dll1loxP/loxP;T(s):Cre embryos without CAG:
DLL1 overexpression (Fig 1Ee and 1Ef). Only two out of 16 embryos of this genotype displayed
regular Uncx4.1 expression in the cranial most somites, which might reflect residual DLL1
activity perhaps due to delayed excision of endogenous Dll1 (Fig 1Eg). The extensively defec-
tive segmentation in Dll1loxP/loxP;T(s):Cre embryos with CAG:DLL4 overexpression directly
shows a functional difference between DLL1 and DLL4 during early embryogenesis: DLL4 is
not able to take over DLL1 function in the paraxial mesoderm during somite formation. Weak
and irregular Uncx4.1 expression in some of these embryos suggest Notch activation at low
levels.
Mice expressing DLL4 in place of DLL1 from the Dll1 locus reveal
divergent function during somitogenesis
To further investigate to which degree DLL4 can compensate for the loss of DLL1 during
somite patterning and in other developmental contexts, we generated mice that express DLL4
from the Dll1 locus instead of endogenous DLL1. To replace endogenous Dll1 with Dll4, we
applied a knock-in strategy inserting a Dll4mini gene into the first and second exons of Dll1
(Fig 2A). Production of DLL4 protein of the correct size from the Dll4mini gene was con-
firmed by Western blot analysis of lysates of CHO cells transiently expressing the Dll4mini
gene (S2 Fig). We generated mice carrying the Dll4mini gene in the Dll1 locus, referred to as
Dll1Dll4ki. As a control, we used the analogous knock-in of a Dll1mini gene into the Dll1 locus
(Fig 2A bottom; Dll1tm2Gos, here referred to as Dll1Dll1ki), which was identical to the Dll4mini
gene with regard to its exon/intron structure, intron sequences and the 5' and 3' UTRs but
encoded DLL1. Homozygous Dll1Dll1ki mice were viable and fertile and appeared phenotypi-
cally normal indicating that the Dll1mini gene can functionally substitute the endogenous Dll1
gene [37].
Functional Divergence of DLL1 and DLL4
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Heterozygous Dll1Dll4ki/+ mice (containing one endogenous copy of Dll1 and one copy of
Dll4ki) were viable and fertile and showed no obvious phenotype except for kinky tails (Fig
2Ba–2Bc, arrow; penetrance 89%; n = 48), a phenotype indicative of irregular somitogenesis
rarely observed in Dll1Dll1ki homozygotes or Dll1 null (Dll1lacZ) heterozygotes (penetrance 15%;
n = 23 and 53, respectively; Fig 2Ba’–2Bc’). In contrast to homozygous Dll1Dll1ki, no homozy-
gous Dll1Dll4ki mice were obtained after birth. At E15.5, Dll1Dll4ki homozygotes exhibited short
body axes, truncated tails and were oedematic (Fig 2C; arrow points at tip of tail) resembling
foetuses with severely reduced DLL1 function [37].
Correct expression of Dll4 in the presomitic mesoderm (PSM) of Dll1Dll4ki embryos was
confirmed by in situ hybridisation using probes specific for the Dll4 ORF or the 3‘UTR (Dll1
exon 11) common to Dll1Dll1ki and Dll1Dll4ki alleles (Fig 2Db, 2Dc and 2Df, black arrowheads).
In situ hybridisation with a specific Dll1 ORF probe confirmed the absence of Dll1 transcripts
in Dll1Dll4ki homozygotes (Fig 2Dj, red arrowhead). Homozygous Dll1Dll4ki embryos showed
strong expression of Dll4 in the neural tube (Fig 2Dc, white arrow), reflecting activation of
the Dll1 promoter in this region [50,51]. Northern blot analysis of Dll1Dll1ki and Dll1Dll4ki
homozygous embryos indicated equal levels of transcription of the transgenes (Fig 2E). In
Dll1Dll4ki/Dll4ki embryos, ectopic DLL4 protein was detected at the plasma membrane of PSM
cells (Fig 2Fa–2Fc). Likewise, DLL1 protein was detected at the surface of PSM cells in homozy-
gous Dll1Dll1ki embryos (Fig 2Fj–2Fl), confirming that DLL4 and DLL1 protein is generated
from their mini genes and targeted to the plasma membrane in vivo. Taken together, these data
show that Dll1Dll4ki mice indeed express Dll4 instead of Dll1 from the Dll1 locus at comparable
levels and confirm our previous observation that DLL4 is unable to support proper mouse
development in the absence of endogenous DLL1.
Cranial-caudal somite patterning critically depends on DLL1-mediated Notch signalling
[38,46,52]. We analysed if DLL4 can functionally replace DLL1 in this process in homozygous
Dll1Dll4ki embryos. Unlike embryos that contained at least one wildtype or Dll1Dll1ki allele,
homozygous Dll1Dll4ki embryos displayed severely reduced and irregular Uncx4.1 expression
(Fig 3A), which indicates disrupted somite patterning and reduced Notch activity in the PSM
due to the inability of DLL4 to replace DLL1. Consistent with defective somite formation and
the shortened body axis observed in E15.5 foetuses, Dll1Dll4ki/Dll4ki axial skeletons were severely
disorganised (Fig 3B). Therefore, expression of DLL4 from the Dll1 locus does not cause a sig-
nificant rescue of the Dll1 somitogenesis phenotype.
Fig 2. Generation ofDll1Dll4ki mice that expressDll4 instead of Dll1 in the endogenousDll1 domains. (A) Targeting strategy to insert a Dll4mini gene
into the Dll1 locus. The Dll1 locus contains 11 exons depicted as black boxes (UTRs as white boxes). The targeting construct is comprised of the Dll4mini
gene [Dll4 cDNA from start codon (ATG) in exon 1 to exon 9 (large red box), Dll1 intron 9, Dll4 exon 10 (small red box), Dll1 intron 10 and Dll1 exon 11 that
encodes only the terminal valine conserved between Dll1 and Dll4 followed by STOP codon and 3‘UTR], a floxed neor cassette, homology regions for
integration between Dll1 start codon and exon 2, and flanking diphtheria toxin genes (DT); insertion of the mini gene is expected to disrupt expression of Dll1.
neor is removed by Cre-recombination. The resulting Dll1Dll4ki allele and the Dll1Dll1ki control are shown below (blue boxes,Dll1mini gene). (B) Heterozygous
adult Dll1Dll4ki mice frequently (89%) displayed a kinky tail (arrow in b) but looked otherwise normal. (C) Heterozygous E15.5 Dll1Dll4ki foetuses (c) were
indistinguishable from wildtype (wt; a) and homozygous Dll1Dll1ki (b) foetuses while all homozygousDll1Dll4ki foetuses (d) displayed shortened body axes and
large oedemas. (D) Dll1 and Dll4 expression in Dll1Dll4ki and Dll1Dll1ki embryos visualised by whole mount in situ hybridisation of E9.5 embryos of the
indicated genotype with a Dll4ORF, Dll1 ex11 (recognises transcripts from both mini genes) and Dll1ORF probe confirmed that Dll4ki alleles expressedDll4
but not Dll1 in Dll1 expression domains (here the PSM, arrowheads). a-c were stained in parallel and colour development was stopped before endogenous
Dll4 expression [49] and background became visible. Homozygous Dll1Dll4ki embryos show strong expression in neuroectoderm (white arrow in c; not visible
in the weaker staining with Dll1 ex11 probe in f). (E) Northern blot analysis of homozygous Dll1Dll4ki and Dll1Dll1ki E11.5 embryos, 2 μg polyA(+)-RNA loaded
per lane, hybridised with 3‘UTR (Dll1 ex11) and β-actin probes; quantification of transgene signals relative to actin is shown at the bottom and indicates
similar expression levels. (F) Visualisation of DLL1 and DLL4 expressed in the PSM of homozygousDll1Dll4ki (a-f) and Dll1Dll1ki E9.5 embryos (g-l) using
specific anti-DLL1 and anti-DLL4 antibodies. Co-staining with anti-panCadherin antibodies, which mark the plasmamembrane, confirms that transgenic
DLL4 and DLL1 predominantly localise to the cell surface (c,l). The lack of DLL1 signal in Dll1Dll4ki (d) and of DLL4 signal in Dll1Dll1ki PSMs (g) confirm the
specificity of stainings. Both in anti-DLL4 and anti-DLL1 antibody stainings of PSMs, we observed spots of high signal intensity that may result from
accumulation of ligands at these sites and that had also been observed in wildtype PSMs stained with anti-DLL1 antibodies [21]. Scale bars, 10 μm; insets
showmagnifications of the dotted boxes in c,l.
doi:10.1371/journal.pgen.1005328.g002
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Remarkably, as anticipated by the kinky tail phenotype of heterozygous Dll1Dll4ki/+ adults
(Fig 2B), E18.5 Dll1Dll4ki/+ skeletons reveal fusions of dorsal ribs and malformations of individ-
ual vertebrae in various regions of the vertebral column (e.g. Fig 3Bd, red arrowheads; 8/12
E18.5 Dll1Dll4ki/+ skeletons displayed apparently irregular vertebrae). Additional examination
of seven Dll1Dll4ki/+ adult skeletons uncovered fused ribs and/or irregular segments in the tail of
all preparations (S3 Fig). A single Dll1 allele is sufficient to support regular segmentation and
Dll1lacZ/+ mice form essentially normal skeletons [53]. Our consistent finding of skeletal irregu-
larities in Dll1Dll4ki/+ mice indicates subtle disturbances during segmentation and suggests that
the Dll1Dll4ki allele has a dominant effect on segmentation.
Fig 3. HomozygousDll1Dll4kimice fail to generate proper somites and form reduced skeletal muscle tissue. Examination of Dll1-dependent (A,B)
somitogenesis and (C-F) myogenesis in (a) wildtype, (b) Dll1lacZ/lacZ, (c) Dll1Dll1ki/Dll1ki, (d) Dll1Dll4ki/+ and (e) Dll1Dll4ki/Dll4ki embryos or foetuses. (A) Uncx4.1 in
situ hybridisation of E9.5 embryos. (B) Skeletal preparations of E18.5 foetuses (Dll1lacZ/lacZ foetuses do not survive until E18.5; red arrowheads indicate
fused ribs or hemivertebrae in heterozygous Dll1Dll4ki skeletons in d). (C)Myogenin in situ hybridisation to visualise differentiating skeletal muscle cells in
myotomes of 17–18 somite stage embryos. (D, E,F) Anti-myosin heavy chain (MHC)-antibody staining of sectioned E15.5 foetuses showing intercostal
muscles (D), the diaphragm (E), and muscles in the cross-section of forelimbs (F); black arrowheads indicate examples of muscle tissue, red arrowheads
show lack of muscle tissue; asterisks label ribs (D) or bones of the forelimb (F).
doi:10.1371/journal.pgen.1005328.g003
Functional Divergence of DLL1 and DLL4
PLOSGenetics | DOI:10.1371/journal.pgen.1005328 June 26, 2015 8 / 31
DLL4 can partially substitute for DLL1 during myogenesis and fully
replace DLL1 during early retinal development
Processes other than somitogenesis in the developing embryo that depend on DLL1–Notch sig-
nalling include myogenesis [37] and retinal development [51]. Embryos lacking DLL1 display
excessive differentiation of myoblasts, which exhausts the progenitor pool and leads to severely
reduced or absent skeletal muscles [37]. Homozygous E9.5 Dll1Dll4ki embryos showed transient
upregulation of the myocyte markerMyogenin [54] as also observed in homozygous Dll1lacZ
embryos (Fig 3C, arrowheads; [37]). At E15.5, they had significantly less skeletal muscle tissue
than wildtype or homozygous Dll1Dll1ki foetuses but clearly more skeletal muscle tissue than
Dll1 null mutants (Dll1lacZ) as shown for the intercostal muscles, the diaphragm and forelimbs
by anti-MHC antibody staining of sectioned foetuses (Fig 3D–3F, arrowheads). These results
indicate that DLL4 can partially substitute DLL1 during muscle cell differentiation and
Dll1Dll4ki behaves like a hypomorphic Dll1 allele.
In the embryonic neural retina, Dll1 and Dll4 are sequentially expressed and can both func-
tion to maintain proliferating progenitors, while they have different functions in retinal fate
diversification [51,55]. In contrast to myogenesis, DLL4 can fully replace DLL1 function in
maintaining neuronal progenitors in the embryonic retina. Whereas Dll1mutants show a strik-
ing disruption of the retinal neuroepithelium with formation of rosettes (Fig 4A), due to pre-
mature differentiation of retinal progenitors [51], both Dll1Dll1ki/Dll1ki and Dll1Dll4ki/Dll4ki retinas
have a normal neuroepithelial organisation with a clear stratification of Chx10+ progenitors
and p27+ differentiating neurons (Fig 4B). Moreover, we find that similar numbers of early
born retinal neurons [retinal ganglion cells (RGCs) and amacrine cells] are present in Dll1Dll1ki
and Dll1Dll4ki retinas (Fig 4C and 4D; n4 retinal sections), confirming that DLL1 and DLL4
functions are interchangeable in regulating early retinal neurogenesis. We have further ana-
lysed DLL4 expression in Dll1Dll4ki/Dll4ki retinas and found it recapitulates the broader Dll1
expression pattern, with the transgenic protein expressed at similar levels as endogenous DLL4
in the retinal neuroepithelium (compare Fig 4Ea–4Ec with 4Eb–4Ed). Together, these results
offer further evidence that the Dll4 transgene is fully functional in Dll1Dll4ki/Dll4ki embryos. The
extent of the functional equivalence of DLL1 and DLL4 depends on the developmental context.
DLL1 and DLL4 activate Notch similarly in vitro
To investigate the functional difference between DLL1 and DLL4 in vitro, we performed co-
culture experiments by mixing cells expressing NOTCH1 receptor or DLL ligands and mea-
sured Notch activation with a reporter in the receptor-expressing cells. Specifically, we used
HeLa cells that express both the NOTCH1 receptor (stable HeLa-N1 cells; [10]) and a transient
Notch activity reporter based on an RBP-Jk promoter-driven Luciferase [56] with CHO cells
stably expressing Flag-tagged DLL1 or DLL4 ligands. To ensure comparability of results, we
integrated single copies of Dll1 or Dll4 ORFs under the control of the CMV promoter into the
identical genomic locus of CHO cells by adopting a site-directed attP/attB recombination sys-
tem (Fig 5A top; S4 Fig; [57]). We established CHO cells with a pre-inserted, randomly inte-
grated single attP site (termed CHOattP; uniqueness of this attP site was confirmed by Southern
blot analysis; S4A and S4B Fig) and recombined Dll1 or Dll4 ORFs into this site (cell lines
termed CHOattP-DLL1 and CHOattP-DLL4; Fig 5A bottom left). Consistent with the expression
from the same genomic locus, independent CHOattP-DLL1 (B5, C6) and CHOattP-DLL4 (B5, D3)
clones expressed DLL1 and DLL4 protein at similar levels (Fig 5B; n = 4 lysates of each clone;
S5A Fig, S3 Table, S5B Fig, S4 Table) and cell surface representation of DLL1 and DLL4 was
similar in all lines (~40%; Fig 5C; n3 biotinylation assays; S5C and S5D Fig, S5 Table).
Functional Divergence of DLL1 and DLL4
PLOSGenetics | DOI:10.1371/journal.pgen.1005328 June 26, 2015 9 / 31
Functional Divergence of DLL1 and DLL4
PLOSGenetics | DOI:10.1371/journal.pgen.1005328 June 26, 2015 10 / 31
Likewise, half-lives of DLL1 and DLL4 proteins were similar, DLL4 being slightly more stable
(S5E and S5F Fig).
Co-culture of HeLa-N1 with either CHOattP-DLL1 or CHOattP-DLL4 (schematically shown in
Fig 5A bottom) led to a>10-fold increase of Notch activity as compared to co-cultures of
HeLa-N1 with CHOattP cells that did not express transgenic DLL1 or DLL4 (Fig 5D; n = 3) con-
firming that all transgenes were functional. DLL4 trended to activate Notch more strongly than
DLL1 (including clone CHOattP-DLL4 B5 whose protein level was slightly reduced in Fig 5B);
the difference between individual clones was not statistically significant in these experiments
and partly significant in similar experiments with other clones (S6A and S6G Fig).
Next, we tested whether coexpression of further factors (LFNG, JAG1) in our cell culture
system differently alters Notch activation by DLL1 or DLL4 and thereby provides a plausible
explanation for the distinct phenotypes. The glycosyltransferase LUNATIC FRINGE (LFNG),
which is expressed in the PSM, is able to modify NOTCH in the trans-Golgi [58,59] and
thereby modulates receptor activation. The Notch ligand JAG1 is expressed in forming
somites [60,61] and can act as a competitive inhibitor of DLL ligands [62,63]. We performed
co-culture assays with HeLa-N1 cells transiently expressing LFNG-HA (S6A–S6C Fig) or with
CHOattP-DLL1 and CHOattP-DLL4 cells coexpressing JAG1 (S6D–S6F Fig) and found no statisti-
cally significant changes in Notch activation.
Also, different glycosylation patterns of the ligands’ extracellular domain could contribute
to differences in their activity. To test this possible influence, we treated co-cultures with tuni-
camycin to prevent N-glycosylation. Blocking N-glycosylation reduced the activity of DLL4 in
cultured cells significantly, but not below DLL1 activity (S6G and S6H Fig), suggesting that dis-
tinct N-glycosylation is an unlikely cause for the observed differences between both ligands.
Collectively, our results do not reveal a difference in the trans-activation potential of DLL1 and
DLL4 that could explain the different segmentation phenotypes of our transgenic DLL1- or
DLL4-expressing mice.
DLL4, but not DLL1, is a strong cis-inhibitor of Notch signalling
Wemodified the co-culture assay by (transiently) expressing the ligands in the HeLa-N1 cells
instead of in the CHO cells (Fig 5E, S7 Fig). In this setting, DLL ligands (expressed in HeLa-N1
cells) can trans-activate Notch in neighboring HeLa-N1+DLL cells (schematically shown in
Fig 5Ec or in detail in S7A Fig); in addition, they can interact with Notch expressed in the same
cell, i.e. in cis. When co-culturing HeLa-N1 cells expressing DLL1 with empty CHO cells
(Fig 5Ea, S7 Fig), activation of Notch signalling was significantly increased as compared to a
co-culture of HeLa-N1 cells expressing no transgenic DLL ligand with empty CHO cells
Fig 4. DLL4 expressed from theDll1 locus rescues DLL1 loss-of-function in the retina. (A) Dll1 null
mutant retinas show epithelial disruption with formation of polarised rosettes in which the apical markers
N-Cadherin (NCad, a) and ZO-1 (ZO1, b) are abnormally present at the central lumen. Ectopic proliferating
progenitors, labelled with PHH3 (b, arrowheads), are located close to the apical lumen of these rosettes. (B)
In contrast, the neuroepithelium of homozygous Dll1Dll1ki and Dll1Dll4ki embryos is correctly organised without
rosettes, and N-Cadherin shows the normal apical localisation close to the retinal pigmented epithelium (a,b).
Mitotic progenitors (PHH3+) are only detected at the apical region of the neuroepithelium (a,b arrowheads). A
normal stratification of CHX10+ progenitors and P27+ differentiating neurons is also observed (c,d). (C, D)
E13.5 homozygous Dll1Dll1ki and Dll1Dll4ki retinas show no significant difference in the number of ISL1+ RGCs
(C) and CRABP+ amacrine cells (D). Cells immunopositive for Islet-1 and Crabp were counted and related to
the total number of cells in the retina (DAPI+). Percentages are shown as mean ± SEM; ns, not significant. (E)
Expression of DLL4 in homozygous Dll1Dll1ki (a,c) and in homozygous Dll1Dll4ki (b,d) E13.5 retinas as
detected by an anti-DLL4 antibody. (c) and (d) are magnifications of (a) and (b), respectively. Endogenous
plus transgenic DLL4 is expressed in more cells in Dll1Dll4ki/Dll4ki as compared to endogenous DLL4
expression in Dll1Dll1ki/Dll1ki while signal strength is similar. Scale bars are 50 μm in (A, B) and 100 μm in (E).
doi:10.1371/journal.pgen.1005328.g004
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(Fig 5Ea’; compare light grey bar “+DLL1” and white bar; n = 6; numbers are normalised to
white bar). Intriguingly, in co-cultures of HeLa-N1 cells expressing DLL4 (with empty CHO
cells), Notch activation was significantly lower than with DLL1 (Fig 5Ea’; compare dark grey
bar “+DLL4” and light grey bar “+DLL1”; n = 6). Given the similar trans-activation potential of
DLL1 and DLL4 (Fig 5D; S6A and S6G Fig), a likely explanation for the different levels of
Notch activation is a higher cis-inhibitory potential of DLL4 than of DLL1.
In order to facilitate the analysis of cis-inhibition, we repeated the experiments shown in
Fig 5Ea and 5Ea’ with the only modification of expressing a DLL ligand in the CHO cells
(CHOattP-DLL1) so as to enhance the level of Notch activation (Fig 5Eb and 5Eb’). In the experi-
ments both without any transgenic DLL ligand in HeLa-N1 and with DLL1 in HeLa-N1, co-
culture with CHOattP-DLL1 cells caused a>10-fold increase of Notch activation. In the HeLa-
N1 cells with DLL4, Notch activation was significantly less, i.e. about 5-fold increased (Fig 5Eb;
n = 6; all numbers in Fig 5Ea’ and 5Eb’ are normalised to the left bar in a’, i.e. HeLa-N1 without
transgenic DLL co-cultured with empty CHO cells, set to 1). These results support cis-inhibi-
tion of Notch by DLL4 resulting in a strong reduction of net Notch activation. In contrast,
DLL1 does not cis-inhibit Notch in this assay (no significant difference between white and light
grey bar in Fig 5Eb’).
To approximate the setting of the embryonic cranial PSM in which every cell expresses both
DLL1 and NOTCH1 [64], we also analysed pure cultures of HeLa-N1 cells expressing either no
transgenic DLL or (transient) DLL1 or DLL4 (Fig 5Ec). Expression of DLL1 enhanced Notch
activation ~15-fold whereas expression of DLL4 increased Notch activation only<5-fold
which was not significantly different from HeLa-N1 cells without transgenic ligand (Fig 5Ec’;
n = 6; numbers in Fig 5Ec’ are normalised to the left bar in 5Ec, i.e. culture of HeLa-N1 without
transgenic DLL, set to 1). These data show that cis-inhibition by DLL4 partially overrides
trans-activation, and reduces Notch activation to<30% in an in vitro setting modeling the
arrangement of ligand and receptor molecules in the PSM.
A conceivable alternative explanation of our in vitro results, which show attenuated
Notch signalling when NOTCH and DLL4 are coexpressed, could be a reciprocal mechanism,
i.e. cis-inhibition of DLL4 by NOTCH1 [18]. To test this possibility, we modified our first
Notch activation assay (Fig 5A bottom, 5D) by transiently coexpressing NOTCH1 (NOTCH1-
deltaC, see Methods) in CHOattP-DLL1 and CHOattP-DLL4 cells. In co-cultures with HeLa-N1
cells containing the reporter (Fig 5Fa and 5Fb, S8 Fig), both ligands activated NOTCH in
HeLa-N1>10-fold irrespective of the presence of NOTCH1 in the CHO cells (Fig 5Fa’ and
5Fb’; n = 3) and we measured no significant difference between trans-activation by DLL1 or
DLL4 as before (Fig 5D). These data indicate that NOTCH1 does not cis-inhibit its ligands.
Fig 5. DLL1 and DLL4 trans-activate Notch with similar efficiency, but only DLL4 is an effective cis-inhibitor. (A) Flag-tagged Dll1 and Dll4ORFs were
inserted into a randomly integrated attP site in CHOattP cells mediated byΦC31 site-directed recombination (upper part). Resulting cells were used in Notch-
activation assays in combination with HeLa-N1 cells as schematically shown below (DLL1 depicted as blue bar; DLL4, red; NOTCH1, grey; HeLa-N1 cells
are encircled in green). (B)Quantification of DLL1-Flag and DLL4-Flag in two independent CHOattP-DLL1 (B5, C6) and CHOattP-DLL4 (B5, D3) cell lines by
Western blot analysis of cell lysates with anti-Flag and anti-β-actin (for normalisation) antibodies showed similar protein levels. (C) Surface biotinylation
assays demonstrated equal surface representation of DLL1 and DLL4 on CHOattP cells. (D) Notch trans-activation assays by co-culture of HeLa-N1 cells
containing an RBP-Jκ:Luciferase reporter with CHOattP-DLL1 or CHOattP-DLL4 cells. All DLL1 and DLL4 clones activated Notch similarly, DLL4 being a slightly
more efficient activator (compare with similar experiment in S6A and S6G Fig). (E) Notch trans-activation and cis-inhibition assays by culturing HeLa-N1 cells
untransfected or transiently transfected with Dll1 or Dll4 expression constructs with or without CHOattP or CHOattP-DLL1 cells as indicated (a-c). Co-culture
conditions a, b and c correspond to Luciferase measurements a’, b’ and c’, respectively. Results show cis-inhibition by DLL4 but not DLL1; for details see
main text. (F) trans-Activation assays (a) without and (b) with NOTCH1 receptor expression in the signal sending CHO cell to test if NOTCH1 cis-inhibits the
ligand activity of DLL1 or DLL4. No cis-inhibitory effect on either ligand was observed (columns a‘ and b‘ correspond to assay conditions a and b,
respectively). (G) trans-Activation and cis-inhibition assays using chimeric DLL1-DLL4 proteins (G top; depicted as red and blue striped bars in a-c). HeLa-N1
cells were transiently transfected with no or DLL4-DLL1ECD or DLL1-DLL4ECD expression constructs and cultured as indicated (a-c). Under all three
conditions, a strong cis-inhibitory activity was detected only for DLL1-DLL4ECD (columns a‘, b’ and c‘ correspond to schemas a, b and c, respectively). Error
bars represent SEM; ns, not significant; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
doi:10.1371/journal.pgen.1005328.g005
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In summary, our cis-inhibition assays (Fig 5E) reveal a functional difference between DLL1
and DLL4 that was not evident in the trans-activation assays (Fig 5D and 5F): DLL4, but not
DLL1, is a potent cis-inhibitor of NOTCH1 and cis-inhibition by DLL4 can significantly reduce
Notch activation. Our in vitro results are consistent with our in vivo data: they can explain both
why DLL4 appears to be a weaker activator of Notch signalling than DLL1 during somitogen-
esis in our transgenic mice and why transgenic DLL4 has a dominant effect on segmentation in
Dll1Dll4ki/+mice (see Discussion and Fig 6). We propose that in the PSM, DLL1 is a more effi-
cient net activator of Notch than (ectopic) DLL4 because it does not efficiently cis-inhibit
Notch.
The cis-inhibitory potential of DLL4 is mediated by its extracellular
domain
In order to identify the protein domain that mediates cis-inhibition by DLL4, we cloned
chimeric Dll1 and Dll4 ORFs by swapping extracellular domains (resulting in DLL4-ICD+-
TM/DLL1-ECD, termed DLL4-DLL1ECD, or DLL1-ICD+TM/DLL4-ECD, termed DLL1-
DLL4ECD; ICD, intracellular domain; TM, transmembrane domain; ECD, extracellular
domain; Fig 5G top). We introduced the chimeric Dll1-4 ORFs transiently into HeLa-N1 cells
and performed co-culture assays analogous to the cis-inhibition experiments with non-chime-
ric DLL1 and DLL4 shown in Fig 5E (Fig 5G; S9 Fig). Measurement of Notch activity showed
similarity between DLL1 and DLL4-DLL1ECD as well as between DLL4 and DLL1-DLL4ECD
(Fig 5Ga’, 5Gb’ and 5Gc’; n = 6; compare with Fig 5Ea’, 5Eb’ and 5Ec’). Particularly the statisti-
cally significant differences between bars in Fig 5Gb’ clearly indicate that DLL4-DLL1ECD
enhances, but DLL1-DLL4ECD reduces Notch activation by DLL1. As both chimeric ligands
localise to the cell surface (S9B and S9C Fig; S6 Table) and are able to trans-activate Notch in a
range similar to DLL1 and DLL4 (S9D Fig) these results show that cis-inhibition is mediated by
the extracellular domain of DLL4. This observation is consistent with studies that showed that
the DSL domain as well as EGF repeats 4–6 of Serrate are essential for cis-inhibition in Dro-
sophila although these EGF repeats are not well conserved between Serrate and Delta ligands
[24,65,66]. Analysis of Notch activation by chimeric proteins in which smaller domains of the
extracellular regions are swapped will help to precisely map the cis-inhibitory domain in DLL4.
Discussion
The presence of several Notch receptors and ligands in mammals offers a multitude of possible
receptor-ligand interactions; whether different combinations of receptor and ligand qualita-
tively or quantitatively vary in their signalling output is largely unknown. In this study, we
focus on the mouse Notch ligands DLL1 and DLL4 and find functional differences in vivo,
which are particularly apparent in the PSM: DLL4 cannot replace DLL1 during axial segmenta-
tion, and a striking dominant segmentation phenotype in Dll1Dll4ki/+ mice hints towards an
inhibitory function of ectopically expressed DLL4 in the PSM. We examined the possibility
that differential cis-inhibition contributes to the phenotype and our in vitro Notch activation
data are indeed consistent with this possibility (Fig 6), but do not exclude that other factors
may contribute (see below).
Direct comparison of DLL1 and DLL4 equally expressed in embryos
uncover context-dependent differences in their ability to activate Notch
Mesodermal expression of DLL1 and DLL4 from theHprt locus on a Dll1mutant background
caused different phenotypes providing first hints that DLL1 and DLL4 are functionally
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Fig 6. Model of Notch signalling in the PSM triggered by DLL1 and ectopic DLL4. Summary combining
our in vivo and in vitro data in three different genetic scenarios (A-C); trans-activation (green arrows) and cis-
inhibition (red bars) in cells of the PSM are schematically depicted on the left, representative skeletal
preparations to visualise the outcome of somitogenesis are shown on the right; references to Figs. in this
paper are given below. (A) In wildtype and Dll1Dll1ki/Dll1ki PSMs, endogenous or transgenic DLL1 (D1) trans-
activates Notch (N) signalling and results in a regularly segmented axial skeleton. (B) In our in vitro assays,
DLL4 (D4) trans-activates Notch with similar efficiency as DLL1 but has an additional strong cis-inhibitory
effect on Notch signalling that partially overrides trans-activation. The reduced net Notch activation in
Dll1Dll4ki/Dll4ki andCAG:Dll4;Dll1loxP/loxP;T(s):Cre PSMs is insufficient to support normal segmentation. (C)
When both DLL1 and DLL4 are expressed (Dll1Dll4ki/+ PSM), cis-inhibition by DLL4 plays a relatively smaller
role, the resulting axial skeletons are mostly regular. However, cis-inhibition by DLL4 reduces the robustness
of Notch signalling resulting in minor malformations (arrow indicates a misplaced rib), which are consistently
seen in Dll1Dll4ki/+ skeletons.
doi:10.1371/journal.pgen.1005328.g006
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different during early embryogenesis: CAG:DLL1 largely rescued the somitogenesis defects
(Fig 1Eb and 1Ec) indicating that expression from this heterologous locus is strong enough to
rescue the Dll1 null segmentation phenotype. In contrast, CAG:DLL4 expressed from the same
locus failed to sufficiently activate Notch (Fig 1Ee–1Eg). Our Dll1Dll4ki knock-in data indepen-
dently confirm and extend the CAG:Dll4 expression data, corroborating the inability of DLL4
to substitute for DLL1 function in the PSM (compare Figs 1Ee, 1Ef and 3Ae). We also show
that the level of redundancy depends on the developmental process: there is essentially no
redundancy during segmentation (Fig 3Ac, 3Ae, 3Bc and 3Be), partial redundancy in myoblast
differentiation (Fig 3C–3F) and full redundancy in retinal progenitor maintenance (Fig 4). The
effects on myogenesis and retinal development confirm that functional DLL4 is expressed from
the Dll1Dll4ki allele (Figs 3De, 3Ee, 3Fe and 4B–4D).
Different protein levels of DLL1 and DLL4 are unlikely to account for the different pheno-
types observed. Both proteins are expressed from identical genomic sites and the comparison
of levels of bicistronic GFP (Fig 1C), transcripts (Fig 2E) and HA-tagged proteins (Fig 1D) con-
firm similar expression levels. Consistently, we find similar steady state levels, surface represen-
tation and half-lives of both ligands in CHO cells (Fig 5B and 5C; S5D–S5F Fig). Furthermore,
immunohistochemistry using anti-DLL4 antibodies show similar levels of endogenous DLL4
and Dll1-driven DLL4ki expression in the retina (Fig 4E) as well as similar localisation of
ectopic DLL4 and endogenous DLL1 at the cell surface within the PSM (Fig 2F). In our mouse
models, we expressed untagged Dll1 and Dll4 transgenes to avoid alteration of protein function
by the tag. As a consequence, we were unable to directly compare DLL1 and DLL4 levels in
vivo and therefore cannot exclude small differences that may have contributed in part to the
observed phenotype; strong differences are not indicated in the controls mentioned above.
Also, it is very unlikely that DLL1 or DLL4 have functions other than interacting with and
activating Notch receptors. Although it has been previously suggested that the intracellular
domain of DLL1 may influence gene transcription in the signal sending cell [67,68], we were
unable to reproduce these in vitro results and showed that overexpression of the intracellular
domain of DLL1 does not cause a phenotype in mice [42]. Collectively, the distinct ability to
cis-inhibit Notch is a plausible explanation for the context-dependent DLL1-DLL4-divergence.
Distinct cis-inhibitory capacity of DLL1 and DLL4 in vitro
The ability of vertebrate DLL homologues to cis-inhibit Notch has been suggested before: over-
expression of truncated DLL1 proteins lacking the intracellular domain in Xenopus, chicken
and mouse embryos show dominant-negative effects on Notch signalling that are likely to be
caused by cis-inhibition of Notch [53,69,70]. In primary human keratinocyte cultures, expres-
sion of DLL1 (and truncated DLL1T) renders cells unresponsive to Delta signals from neigh-
bouring cells and controls differentiation of stem cells [71]. Our data show for the first time
that DLL4 is a strong cis-inhibitor of Notch signalling, far stronger than DLL1. We have exam-
ined cis-inhibition in various types of cultures, in NOTCH- and DLL-expressing HeLa cells
with and without co-culture of empty or DLL-expressing CHO cells and with chimeric DLL1-4
proteins (Fig 5E and 5G). Furthermore, we have tested cis-inhibition of DLL1 and DLL4
ligands by NOTCH1 (Fig 5F). All those assays consistently show a strong reduction of Notch
signalling by DLL4 when coexpressed with NOTCH1.
In our assays, DLL1 had no obvious cis-inhibitory effect (Fig 5Eb’; n = 6), which differs
from earlier reports showing that vertebrate DLL1 proteins can cis-inhibit NOTCH1 [20,72–
74]. This is likely due to different assay conditions: in these previous studies, DLL1 was derived
from different vertebrate species or differently tagged, or different cell systems or higher ligand
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concentrations were used. In studies in which cis-inhibition of Notch by Delta and Serrate was
compared, Delta displayed a relatively weaker cis-inhibitory potential [75,76].
The ability for strong cis-inhibition resides in the extracellular domain of DLL4 (Fig 5G)
that physically interacts with the Notch extracellular domain. Possible causes for the higher
cis-inhibitory potency of DLL4 as compared to DLL1 include a potentially higher Notch cis-
binding affinity of DLL4 as determined for the trans-interaction in vitro [34] or different glyco-
sylation patterns in the extracellular domains of DLL1 and DLL4 (DLL4 contains an additional
O-fucosylation site in EGF5 and four additional N-glycosylation sites, three of which reside in
the N-terminal domain, which is essential for Notch activation; e.g. [19]; sites predicted by
www.cbs.dtu.dk/services/NetOGlyc).
cis-inhibition by DLL4 in vivo
Our in vitro findings provide a possible explanation why DLL1 supports regular somite forma-
tion whereas DLL4 with its reduced net Notch activation potential is unable to do so. Heterozy-
gous Dll1Dll4ki/+ mice consistently exhibit kinky tails and irregular vertebrae (Figs 2B and 3Bd;
S3 Fig) despite the presence of one wildtype Dll1 allele, which should be able to support regular
somitogenesis [53]. This finding strongly supports an in vivo inhibitory effect of DLL4 in the
PSM, in which Dll4 is ectopically expressed at physiological levels (similar to the endogenous
Dll1 levels; Fig 2E). Skeletal malformations observed in Dll1Dll4ki/+ mice are distinct from phe-
notypes observed upon mild overexpression of Dll1 in the paraxial mesoderm that include
fused or split vertebral bodies and reduction of costal heads of ribs [77]. This supports the view
that cis-inhibitory DLL4 acts in a dominant-negative manner partially overruling Notch activa-
tion by wildtype DLL1 causing axial skeleton defects in Dll1Dll4ki/+ mice, similar to the effect of
a truncated dominant-negative form of DLL1 expressed in the paraxial mesoderm [53]. An
alternative explanation for the dominant segmentation effect in heterozygous Dll1Dll4ki/+ mice
could be a competition between DLL4 and DLL1 for NOTCH binding sites with DLL4 binding
NOTCHmore efficiently but activating it less efficiently than DLL1; although DLL1 has not
been shown to be a more potent activator of NOTCH in vitro (Fig 5D; S6A, S6D and S6G Fig;
[33,34]) we cannot exclude that this is the case in certain cellular contexts.
cis-Inhibition has been demonstrated to play a physiological role during fly development at
the dorso-ventral border of the wing imaginal disc [15,16] and in photoreceptor precursors of
the eye [17]. In vertebrates, the occurrence of cis-inhibition under physiological conditions is
less clear but probable (see previous section). We did not observe apparent phenotypes in
Dll1Dll4ki/+mice that indicate dominant-negative effects of DLL4 outside the PSM. However,
we hypothesise that cis-inhibition may occur in the foetal arterial endothelium, where DLL1,
DLL4 and NOTCH1 are coexpressed and where loss of DLL1 abolishes NOTCH1 activation
[29], possibly due to cis-inhibition by DLL4.
The PSM is particularly well suited to test the functionality of Notch ligands in vivo because
DLL1 is the only activating ligand endogenously expressed in this tissue [78] and Dll4mutants
have no somitogenesis phenotype [39,40], so the analysis of Notch signalling is not compli-
cated by the presence of several activators or confounded by composite phenotypes. However,
two receptors, NOTCH1 and NOTCH2, are expressed in the PSM and may differ in their
response to DLL1 or DLL4 binding.
The situation in myoblasts and other tissues is less clear. Outside the PSM, receptor and
ligand expression typically exclude each other so that cis-inhibition can occur only during the
short process in which the fate as receptor- or ligand-expressing cells is established [76,79,80].
That way, cis-inhibition may also be responsible for differences between DLL1 and DLL4
observed during myogenesis (Fig 3D–3F). Other reasons may contribute to or cause these
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differences: Firstly, further Notch receptors and ligands are expressed during myogenesis [81].
The contribution of individual Notch receptors to myogenesis is unknown but their function
could vary [82]. Also, different ligands, including DLL1 and DLL4, have been shown to activate
different Notch targets depending on the cell type in vitro [83,84]. A future thorough analysis
of the functional divergence between DLL1 and DLL4 in myoblasts should aim at identifying
the involved receptors and modulators (perhaps by in vitro analyses of myogenic or meso-
dermal progenitor cells including knock-down of individual factors) in order to understand
the mechanisms underlying the observed phenotype.
Secondly, other processes may cause the divergence, e.g. modification of the ligands or
receptors by glycosylation (may also play a role in the PSM). Activation of Notch by its ligands
can be modulated by Fringe proteins. While glycosylation of Notch by LFNG enhances interac-
tion with DLL1 in C2C12 cells [85] and with DLL4 in T cells in vitro [86], it appears to attenu-
ate Notch signalling in the PSM [64,87]. However, we did not observe any shortcomings of
DLL4 in the ability to trans-activate NOTCH1 compared to DLL1 when LFNG was present in
the receptor-presenting cell (S6A–S6C Fig). The trans-activation potential of DLL1 and DLL4
could vary under certain conditions in vivo, perhaps depending on the glycosylation status,
although our in vitro assays did not reveal any difference. Finally, the different extent of the
functional difference between DLL1 and DLL4 observed in the PSM and during myogenesis
may reflect the fact that mild changes of DLL1 activity affect the delicate Notch signalling in
the PSMmore readily than outside the PSM because somite patterning appears to be particu-
larly sensitive to reduced Notch activity [88].
In conclusion, our genetic studies revealed a context-dependent functional divergence of
the NOTCH ligands DLL1 and DLL4 in mice and provide a basis for a more extensive mecha-
nistic analysis of this divergence in future studies. These will identify the relevant protein
domain(s) and biochemical parameters and contribute to our understanding how different
combinations of receptors and ligands determine the outcome of Notch signalling.
Materials and Methods
Cloning of constructs
CAG:Dll1 and CAG:Dll4 Hprt targeting constructs. Untagged Dll1 and Dll4 ORFs were
PCR-amplified with primer pairs Dll1-for (SpeI) ACT AGT GCC ACC ATG TCT TAC GGT
CAA GGG TCC AGC / Dll1-rev (AseI) GAT CAT TAA TTC ACA CCT CAG TCG CTA TAA
CAC ACT CAT CCT TTT C and Dll4-for (NheI) GCT AGC AAT TCA TGA CGC CTG CGT
CCC G / Dll4-rev (NdeI) CAT ATG TTA TAC CTC TGT GGC AAT CAC. Restriction sites
introduced via primers were used to insert PCR products into NheI-NdeI sites of a shuttle vec-
tor containing IRES-GFP. Dll-IRES-GFP constructs were then subcloned into pMP8.CAG-Stop
using restriction enzymes SwaI and MluI. HA-tagged versions of the above constructs for
quantification of protein levels (Fig 1D) were cloned in a similar way: PCR primers for
Dll1-HA were Dll1-for (SpeI; see above) / Dll1-HA-rev (AseI) ATT AAT CTA AGC GTA ATC
TGG AAC ATC GTA TGG GTA CAT ACT AGA CAC CTC AGT CGC TAT AAC ACA C. A
C-terminal HA-tag was introduced to the Dll4 ORF via gene synthesis (Life technologies) of
the flanking regions of Dll4-HA lacking the central AflII/EcoRV Dll4 fragment that was cloned
into the synthesised fragment; the complete Dll4-HA was cloned into NheI/NdeI of the shuttle
vector. HA-tagged constructs were Cre-recombined in bacteria of the recombination strain
SW106 (NCI at Frederick).
Dll4ki targeting construct. The Dll1mini gene in the Dll1Dll1ki (Dll1tm2Gos; Fig 2A bottom;
[37]) targeting vector was replaced with a Dll4mini gene by a 3-point ligation of a NsiI/KpnI
fragment of the Dll1ki targeting construct (containing DT, the 5‘ homology region and the
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5‘UTR of Dll1 exon1), a NsiI/SmaI fragment of the same Dll1ki targeting vector (containing
the vector backbone with ampr, 3‘ homology region and floxed PGK-neor) and a KpnI/PmeI
fragment (containing the complete Dll4 ORF with start codon ATG followed by 3 Stop codons
and—as an inactive remainder of a precursor clone—the genomic Dll1 region from the last 42
bp of exon 9 to exon 11; gene structure resembled a Dll3ki targeting vector, [21]). To adjust the
gene structure of the Dll4ki targeting vector to that of control Dll1ki, a 1,466 bp MfeI/BsiWI
fragment (comprising last 134 bp of Dll4 exon 9, the genomic Dll1 remainder from exon 9–11
and 154 bp downstream) was replaced with a synthesised 1,293 bp MfeI/BsiWI DNA fragment
(comprising Dll4 exon 9 from the MfeI site, Dll1 intron 9, Dll4 exon 10, Dll1 intron 10, Dll1
exon 11 and 154 bp downstream; Life technologies); the only remaining difference between
Dll4ki and control Dll1ki targeting vectors were the coding regions of Dll4 or Dll1mini gene
(ORFs from exon 1 to exon 9 and separate exon 10; exon 11 contains only one coding amino
acid, i.e. a conserved valine).
CMV-Dll4mini-pA. The Dll4kimini gene was released from the Dll4ki targeting construct
with SacI/XbaI and cloned into expression vector pTracer-CMV (Invitrogen). Dll1 and Dll4
ORFs (Flag-tagged) were cloned into the multiple cloning site of pTracer-CMV and used as
controls.
pHZ-attP-Jag1Myc. A DNA fragment containing Jagged1-Myc and flanking frt sites was
synthesised (Life technologies) and inserted into the MluI site of the pHZ-attP vector [57].
Dll1-attB, Dll4-attB and chimeric Dll1-4-attB. The eGFP gene was removed from pNC-
attB vector [57] by AfeI/HindIII digest, blunting ends with T4 DNA-Polymerase (Roche) and
religation; Flag-tagged Dll1 and Dll4 ORFs were released from pTracer-CMV and inserted into
pNC-attB-deltaGFP using restriction enzymes EcoRI/BamHI. To generate an alternative con-
struct with HA-tagged DLL4, the HA-tag was added to the Dll4 ORF by PCR with primer pair
Dll4.up (EcoRI) GAA TTC ACC ATG ACG CCT GCG TCC CGG AGC G / Dll4.lowHA
(NotI) GCG GCC GCT TAT TAT TAA GCG TAG TCT GGA ACG TCG TAT GGG TAT
ACC TCT GTG GCA ATC ACA CAC TCG. Dll4-HA was inserted into EcoRI/NotI sites of
pTracer-CMV and subcloned with PmeI/XbaI into AfeI/XbaI sites of pNC-attB-deltaGFP. Chi-
meric Dll1-4 constructs were partly generated by gene syntheses (Life technologies) and cloned
into pNC-attBdeltaGFP. For Dll4-Dll1ECD an NdeI-EcoRV fragment containing a part of Dll1
ECD and complete Dll4 TM and ICD synthesised; a BglII/NdeI Dll1 ECD fragment was
inserted into the gene synthesis vector and the whole chimeric ORF was inserted into pNC-
attBdeltaGFP-Dll4 as an EcoRI/EcoRV fragment. For Dll1-Dll4ECD a BspEI/MfeI fragment
containing part of Dll4 ECD, Dll1 ICD and part of Dll1 ICD was synthesised. Dll1 ICD was
inserted as a MfeI/XbaI fragment and Dll4 ECD as a ScaI/BspEI fragment; the chimeric ORF
was then inserted into pNC-attBdeltaGFP-Dll4 as a ScaI/XbaI fragment. pNC-attBdeltaGFP
with chimeric Dll1-4 were used as transiently transfected expression vectors (CMV promoter).
Generation and husbandry of transgenic mice
Ethics statement. All animal experiments were performed according to the German
rules and regulations (Tierschutzgesetz) and approved by the ethics committee of Lower Sax-
ony for care and use of laboratory animals LAVES (Niedersächsisches Landesamt für Verbrau-
cherschutz und Lebensmittelsicherheit). Mice were housed in the central animal facility of
Hannover Medical School (ZTL) and were maintained as approved by the responsible Veteri-
nary Officer of the City of Hannover. Animal welfare was supervised and approved by the
Institutional Animal Welfare Officer (Tierschutzbeauftragter).
Mouse strains. Wildtype (CD1 and 129Sv/CD1 hybrids), Dll1loxP/loxP [32], Zp3:Cre [45], T
(s):Cre [46], Chx10:Cre [89].
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Generation of transgenic mice. Linearised targeting constructs were electroporated into
E14TG2a (used for targeting of theHprt locus; carry a deficientHprt locus enabling HAT selec-
tion [90]) or 129Sv/cast (to target Dll1) mouse embryonic stem cells. Correct homologous
recombinant clones were identified by long range PCR (Expand High Fidelity PCR System,
Roche; primer sets for Hprt locus, HPRT-5‘typ.for2 ACC TGT TAG AAA AAA AGA AAC
TAT GAA GAA CT / HPRT-CAG.rev1 GGC TAT GAA CTA ATG ACC CCG TAA TTG
ATT ACT ATT A; for Dll1 locus, EGF3’#1 TGT CAC GTC CTG CAC GAC G / EGF3’#2 GGT
ATC GGA TGC ACT CAT CGC) and Southern blot analysis (5’ probe was a 316 bp BamHI/
AvaII fragment 3.8 kb upstream of Dll1 exon 1; 3’ probe was a 528 bp PCR fragment, CCT
GTG AGA CTT TCT ACG TTG CTC / CAC AAC CAT GTC ACC TTC TAG ATT C, in Dll1
intron 5) and used to generate chimeric mice.The neor cassette was removed in the female
germ line using ZP3:Cremice. For embryo collection, mice were sacrificed by cervical disloca-
tion, for adult skeletal preparations, mice were asphyxiated with CO2.
Genotyping. Genomic DNA was isolated from ear or tail biopsies or yolk sacs of embryos
and used as template in PCRs with the following primer pairs: CAG:Dll1 GAC GCT GAG
GGG TAT GTG ATG / CTT GAG GCA TAC GCG AAA GAA GGT C; CAG:Dll4 GAC GCT
GAG GGG TAT GTG ATG / GCT CGT CTG TTC GCC AAA T; Cre-recombined CAG:Dll1
or -4 CGA GGT GAA GTT CGA GGG CGA C / GGG CAA CAG AGA AAT ATC CTG TCT
C; gender (Y-chromosome PCR) CTG GAG CTC TAC AGT GAT GA / CAG TTA CCA ATC
AAC ACA TCA C; Cre GCC TGC ATT ACC GGT CGA TGC AAC GA / GTG GCA GAT
GGC GCG GCA ACA CCA TT; Dll1wt ACT CAC CTC TCC GTG GAC TGA AAG C / GGA
GCT CCA GAC CTG CGC GGG; unrecombined Dll1loxP GCA TTT CTC ACA CAC CTC /
GAG AGT ACT TGA TGG AGC AAG; Cre-recombined Dll1loxP CAC ACC TCC TAC TTA
CCT GA / TGA AGT GTG GAC CCA TCA TC; Dll1Dll4ki AAG GAC AAC CTA ATC CCT
GCC G / TGC CAC ATC GCT TCC ATC TTA C; Dll1Dll1ki CCT GGT TTC CGT GGA GCA
TGG ACA / GGG TGC AGG AAG AGG AGA GGG CAG; Dll1lacZ ACT CCT GGG TCT TTG
AAG AAG / TGT GAG CGA GTA ACA ACC CGT CGG ATT.
Analyses of gene expression patterns and phenotypes
Whole mount in situ hybridisation. Embryos were collected in ice cold phosphate
buffered saline (PBS) and fixed over night in 4% formaldehyde/PBS at 4°C. Hybridisation was
performed following standard procedures [91] with digoxigenin labelled cDNA probes com-
prising the whole ORFs of Dll1 or Dll4, Dll1 exon 11, ~1kb of the 5‘ region ofMyogenin cDNA
[92] and Uncx4.1 [47]. Photos were taken with the Leica Z6 APO microscope and Leica Fire-
Cam software.
Antibody staining. E15.5 embryos were fixed over night in 4% formaldehyde/PBS at 4°C,
dehydrated in methanol and 2-propanol, embedded in paraffin and sectioned sagittally
(10 μm). Antigene unmasking was performed by cooking sections 20 min in 10 mM Tris
pH9.5/1 mM EDTA. Sections were blocked in 1% BSA/2% goat serum 1h at room temperature,
incubated with a monoclonal mouse anti-myosin antibody (skeletal, fast, My32; dilution 1:250;
Sigma-Aldrich) in blocking solution over night at 4°C, incubated with secondary goat biotiny-
lated anti-mouse antibody (BA 9200; 1:200; Vector Laboratories) in blocking solution 1 hour at
RT and stained with VECTASTAIN Elite ABC Kit and DAB (Vector Laboratories). Pictures
were taken with a Leica microscope DM5000 B and Leica FireCam software.
Immunofluorescence. Embryos were fixed in 4% formaldehyde at 4°C, then cryopro-
tected in 30% sucrose and embedded in 7.5% gelatin:15% sucrose. Cryostat sections (12 μm)
were used for immunofluorescence. Retinal sections were degelatinised at 37°C for 20 min, fol-
lowed by treatment with 0.1 M glycine for 10 min at room temperature. Permeabilisation was
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performed using 0.5% TritonX-100 for 10 min. In the case of CHX10, P27 and ISL1 immuno-
histochemistry, antigen retrieval was performed after degelatinisation by boiling slides for 10
min in 0.01 M citrate buffer (pH 6). Primary antibodies used were anti-DLL4 (AF1389, R&D;
1:100), anti-N-Cadherin (610920, BD Transduction Lab; 1:100), anti-PHH3 (06–570, Upstate
Biotech; 1:500), anti-ZO-1 (33–9100, Zymed; 1:50), anti-CHX10 (X1180P, Exalpha; 1:100),
anti-P27 (PA5-27188, NeoMarkers; 1:100), anti-ISL1 (40.2D6, DSHB 1:100), anti-CRABP
(Affinity Bioreagents 1:1,000). DAPI counterstain was used to visualise nuclei. Images were
taken using a Leica DM5000 BA fluorescence microscope. A total of ~10,000 ISL1+ cells were
counted in 4 control and 5 Dll1Dll4ki embryos and a total of ~2,500 CRABP+ cells were counted
in 4 control and 4 Dll1Dll4ki embryos.
Whole mount immunofluorescence. Immunofluorescence staining of E9.5 old embryos
was performed as described in [93]. Primary antibodies used were anti-DLL4 (AF1389, R&D;
1:50), anti-panCadherin (C1821, Sigma; 1:250) and anti-DLL1 (1F9 [21]; 1:50). Alexa-488/555
conjugated secondary antibodies (Invitrogen; 1:100) were used. Images were taken using
OLYMPUS FV1000.
Venus fluorescence. Dissected E8.5 embryos in ice cold PBS were analysed under a Leica
microscope DMI6000 B using LAS AF software.
Skeletal preparations. Skeletons of E18.5 mouse foetuses and adult mice were dissected
and stained with Alcian blue and Alizarin red following standard procedures [53].
Analyses of gene expression levels
Western blot analysis. Cells/embryos were lysed in 2x sample buffer (0.125 M Tris pH
6.8/4% SDS/20% glycin/5% beta-mercaptoethanol/0.025% bromphenol blue). Proteins were
separated by SDS-PAGE and transferred to Immobilon-P Transfer membranes (Millipore) by
wet tank blotting. Blots were blocked in 5% nonfat dried milk powder (AppliChem) in PBS/
0.1% Tween 20. Primary antibodies: anti-HA HRP (rat monoclonal; clone 3F10, Roche; HRP,
horseradish peroxidase-conjugated; 1:5,000–1:10,000), anti-Flag HRP (mouse monoclonal;
clone M2, Sigma), anti-GFP HRP (mouse monoclonal; MACS molecular; 1:10,000), anti-DLL1
(1F9, rat monoclonal, [21] 1:1,000), anti-DLL4 (rabbit polyclonal against peptide C-GKIWRT-
DEQNDTLT; BioGenes; 1:50–1:100), anti-β-actin (mouse monoclonal; MP Biomedicals;
1:250,000–1:500,000), anti-β-tubulin I (Sigma; 1:500,000). Secondary antibodies: anti-mouse
HRP, anti-rat HRP, anti-rabbit HRP (Amersham; 1:10,000). HRP was detected with ECLWest-
ern Blotting Detection Reagents (Amersham) with the Luminescent Image Analyser LAS-4000
(Fujifilm); signals were quantitated with ImageJ software.
Northern blot analysis. E11.5 mouse foetuses were collected in ice cold PBS and immedi-
ately frozen and kept at -80°C in lysis buffer (100 mM Tris pH7.5/500 mM LiCl/10 mM
EDTA/1% LiDS (lithium dodecylsulphate)/5 mMDTT). polyA(+) RNA was isolated with
magnetic OligodT beads (Novagene) following the manufacturer’s instructions. 2 μg of polyA
(+) RNA was separated on a 1% agarose gel containing 6.6% formaldehyde in 1x MOPS buffer.
RNA was transferred to a nylon membrane (Hybond-N+; Amersham) with 20x SSC, the mem-
brane washed with 5x SSC and UV-crosslinked (Stratalinker, Stratagene). The blot was hybri-
dised with radioactively labelled probes (Dll1 3‘ UTR, first 362 bp of Dll1 exon 11 PCR-
amplified with GTG TAA GAT GGA GC GAT GTG GCA / GGC AGT TGT GTT TCT AGT
TCA AGG AAA G, RNA probe; actin, 1.2 kb SalI/SacI fragment of β-actin cDNA, DNA probe)
over night at 65°C in Church buffer (300 mMNaPi pH6.7/5 mM EDTA/7% SDS). Signals were
detected with a phospho imager (FLA-7000; Fujifilm) and quantified using ImageJ software.
Southern blot analysis. DNA was isolated from CHOattP cells, digested with various
restriction enzymes (EcoRI, EcoRV,HindIII,MfeI, XbaI; NEB) over night and separated on a
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0.7% agarose gel. Blotting, crosslinking, hybridisation (radioactively labelled DNA probe, i.e. a
DraI/HindIII fragment of the pNZ-attP vector [57] containing the attP site and part of the
Hygr gene) and signal detection as for Northern blot analysis.
Cell culture experiments
Culture and transfection. CHO and HeLa-N1 cells were cultured in DMEM/F12 (Invitro-
gen) cell culture medium with 10% FCS (Biochrom AG), 1% GlutaMAX (Gibco) and 1% Pen/
Strep (Gibco). Transfection of cells was performed with PerFectin (Genlantis) following the
manufacturer’s instructions. CHO cells transiently expressing the Dll1Dll4ki mini gene were
transfected on 6-well dishes with 2 μg of DNA and lysed after 18 hours. CHOattP-JAG1Myc cells
were generated by electroporation of pHZ-attP-Jag1Myc plasmid into CHO cells and selection
with 500 μg/ml Hygromycin B (S4 Fig). Integration of the attP site was checked by PCR using
primers attP-for TAC TGA CGG ACA CAC CGA AGC / attP-rev GAA CGG CAC TGG TCA
ACT TGG. CHOattP-JAG1Myc cells were transfected with pCAGGs-Flpo [94] and Jag1-Myc was
deleted by Flippase mediated recombination of the flanking FRT sites, thereby generating
CHOattP cells. After transfection with attB vectors [57], cells were selected for correct integra-
tion with 250 μg/ml Zeocin.
Biotinylation assay. Cells were plated on 6 cm dishes. At 80% confluence, the cells were
washed twice with ice cold PBS supplemented with 0.1 mM CaCl2 and 1 mMMgCl2 (PBS-C/
M). After incubation on ice for 10 min with PBS-C/M, cells were treated with Sulfo-NHS-LC
(Pierce; 0.25mg/ml in PBS-C/M) for 40 min to bind all proteins present on the cell surface. To
quench the biotin reaction, cells were washed twice with PBS-C/M and incubated with 100
mM glycine in DMEM on ice for 30 min. After washing with PBS, the cells were lysed in lysis
buffer [50 mM Tris-HCl pH7.6, 150 mMNaCl, 1 mM EDTA, 1% TritonX-100, 0.25% DOC
(Sodium-desoxycholate), 0.1% SDS] supplemented with Complete Protease Inhibitor Cocktail
Tablets (Roche) on ice for 30 min. Next, the samples were sonified and centrifuged at 10,000 x
g for 15 min at 4°C to remove cell debris. Using NeutrAvidin beads (Thermo Scientific) pre-
washed in lysis buffer, biotinylated proteins were immunoprecipitated and analysed [95]. Pro-
tein amounts were calculated as follows: total DLL protein in lysate = signal intensity of input x
total volume of lysate/loaded volume; DLL protein on surface = signal intensity of IP x total
volume of IP eluate/loaded volume; relative cell surface levels = DLL protein on surface / total
DLL protein in lysate.
trans-activation assay. For analysis of Notch trans-activation, HeLa-N1 cells were trans-
fected with 2 μg of RBP4-Luciferase reporter and 0.5 μg of firefly renilla-Luciferase on 6-well
dishes using PerFectin (Genlantis). To analyse the effect of NOTCH1 glycosylation, HeLa-N1
cells were transiently transfected with 1.5 μg of attB-LfngHA. For analysis of cis-inhibition,
HeLa-N1 cells were transiently transfected with 200 ng of Flag-tagged attB-Dll constructs. For
analysis of the cis-inhibitory potential of NOTCH1, the ligand expressing CHOattP-DLL cells
were transfected with 6 μg of Flag-tagged NOTCH1ΔC (NOTCH1 lacking the C-terminal 56
amino acids) expression vector. Expression of proteins was validated by Western blot analyses.
Co-cultivation of HeLa-N1 and CHOattP cell lines was performed with 1.25 x105 cells each on
12-well dishes for 24 hours; pure HeLa-N1 cultures with 2.5 x105 cells on 12-well dishes for 48
hours. N-linked glycosylation was blocked by cultivating the cells in medium containing 1 μg/
ml tunicamycin for 22 hours. For Luciferase detection the Dual-Luciferase Reporter Assay Sys-
tem (Promega) was used according to the manufacturer’s instructions; probes were analysed in
a TurnerBioSystems luminometer with Glomax software. Each (co-)culture was performed in
duplicates and every lysate was measured twice; the mean of the four measurements counted as
n = 1.
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Immunofluorescence. Cells were fixed in 4% formaldehyde for 10 minutes on ice, per-
meabilised with 1% Triton-X100 for 15 minutes at RT and washed in PBS for 30 minutes. Cells
were then incubated for 5 minutes in 0.2% glycine, washed for 15 minutes with 0.1% Triton-
X100 in PBS for 30 minutes, blocked with 5% FCS/0.1% Triton-X100/PBS for 1 hour at RT and
incubated for 1 hour with primary antibodies (anti-Flag, clone M2, Sigma; 1:4,000), washed
again with 0.1% Triton-X100 in PBS for 30 minutes and incubated with secondary antibodies
(anti-mouse-Alexa488, Invitrogen; diluted in blocking solution 1:100) for 1 hour. After another
washing step (0.1% Triton-X100 in PBS for 30 minutes) nuclei were stained by incubating the
cells with TO-PRO3 (Invitrogen; diluted 1:1,000 in PBS) for 30 minutes at RT. After washing
in PBS and water cells were mounted in ProLong-Gold antifade reagent (Life Technologies)
and analysed with a Leica DM IRB microscope with a TCS SP2 AOBS scanhead.
Determination of half-lives of DLL1-Flag and DLL4-Flag. Cells were cultured in
medium containing 100 μg/ml Cycloheximide and were lysed in 2x sample buffer (0.125 M
Tris pH 6.8/4% SDS/20% glycin/5% beta-mercaptoethanol/0.025% bromphenol blue) after
30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, 8 hours, 10 hours, 12 hours, 14 hours,
16 hours, 18 hours, and 24 hours. Protein levels were analysed onWestern blots and quantified
with ImageJ software. Half-lives were determined using Prism software (GraphPad).
Statistical analyses
Statistical analyses were performed using Prism software (GraphPad). Luciferase measure-
ments were analysed by one-way ANOVA and activities obtained with each protein were com-
pared using Bonferoni’s Multiple Comparison Test with a significance level of 0.05. Means for
all three DLL1-and DLL4-HA clones in Fig 1D, cell counts in the retina and cell surface levels
of chimeric ligands were analysed using the Student’s t-test.
Supporting Information
S1 Fig. Quantification of GFP, DLL1-HA and DLL4-HA expressed from theHprt locus. (A)
Exemplary blot for the analysis of GFP levels expressed in transgenic embryos (Fig 1B and 1C)
by Western blot analysis of embryo lysates with anti-GFP antibodies and anti-β-actin (for nor-
malisation) to compare levels of CAG:DLL1- and CAG:DLL4-IRES-Venus expression. (B)
Direct comparison of DLL1-HA and DLL4-HA levels in three independent embryonic stem
cell clones (ES cells, E14TG2a) with single copy integrations of CAG:Dll1-HA (clones A11, B2,
B7) and CAG:Dll4-HA (clones A1, A10, B10) into theHprt locus (Fig 1D) by Western blot
analysis using anti-HA and anti-β-tubulin (for normalisation) antibodies. Three independent
lysates of each clone (experiment 1–3) were analysed twice (WB1, WB2); ES cells, lysate of
unelectroporated E14TG2a cells as negative control.
(TIF)
S2 Fig. Correct DLL4 protein expression from the Dll4minigene. In vitro test of DLL4 pro-
tein expression from the Dll4mini gene (under the control of a CMV promoter) in comparison
to Dll4 cDNA and Dll1 cDNA in transiently transfected CHO cells. Cell lysates were analysed
with DLL4, DLL1 and anti-β-actin (loading control) antibodies on a Western blot. Identical
signals obtained from the Dll4mini gene and Dll4 cDNA at the size of ~100 kDa confirmed
correct expression of DLL4 protein from the Dll4mini gene; anti-DLL4 and anti-DLL1 anti-
bodies specifically recognised the correct DLL paralogue and gave no endogenous CHO signals
in the negative control (untransfected CHO cells). As the cells were transfected transiently, this
blot cannot be analysed quantitatively.
(TIF)
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S3 Fig. Defects in the axial skeletons of heterozygous Dll1Dll4ki/+ adults. Skeletal prepara-
tions of seven adult Dll1Dll4ki/+ males (1–7; 4 to 8 months old) are largely normal but consis-
tently exhibit irregularities (arrows) in the rib cage (top) and/or tail (bottom) suggesting a mild
dominant-negative effect of transgenic Dll4 (see main text and Discussion).
(TIF)
S4 Fig. Validation of unique attP site integration in CHOattP cells. (A)Map of the genomic
integration of the pHZ-attP construct containing attP site, Hygr, Zeor and frt-flanked Jagged1
(Jag1). The position of restriction sites and of the probe used for Southern blot analysis are
indicated. The flanking genomic sequence and position of restriction sites outside the vector is
unknown. (B) Southern blot analysis of DNA isolated from CHOattP-JAG1 cells shows a single
product for each digest indicating a single genomic integration of the attP construct (the 3.3 kb
EcoRI fragment is entirely derived from the integrated construct and served as a control). (C)
FC31 integrase-mediated insertion of Dll1 and Dll4 into CHOattP-JAG1 generates CHOattP--
JAG1-DLL1 or CHOattP-JAG1-DLL4 cells used in S6D Fig; JAG1 is Myc-tagged, DLL1 and DLL4 are
Flag-tagged. (D) Excision of Jag1 by FLP recombination results in CHOattP cells that were sub-
sequently used for the generation of CHOattP-DLL1 and CHOattP-DLL4 cells.
(TIF)
S5 Fig. DLL1 and DLL4 stably expressed in CHOattP cells: Protein levels, surface localisa-
tion and half-lives. (A) Exemplary Western blot used for the analysis of protein levels in Fig
5B. CHOattP cells were used as negative control; β-actin was used for normalisation. (B)
Extended Western blot analysis of protein levels including additional clones of CHOattP-DLL1
and CHOattP-DLL4. Expression levels varied to some degree, but DLL4 levels were not below
DLL1 levels. Clone CHOattP-DLL1 C6 is the same in Fig 5B and can be used to compare values
between both Figs. Error bars represent SEM; ns, not significant; , P<0.05; , P<0.01. (C)
Exemplary Western blot used for the quantification of cell surface protein levels by biotinyla-
tion in Fig 5C. The protein amount was quantitated and the relative protein surface level was
calculated as described in Materials and Methods. (D) Immunocytochemistry of fixed
CHOattP-DLL1 and CHOattP-DLL4 cells. Flag-tagged ligands were visualised using anti-Flag anti-
bodies. DLL1 and DLL4 are present at the cell surface. (E,F) Determination of DLL1 and DLL4
protein half-lives. (E) DLL1 and DLL4 half-lives analysed using two different clones for each
cell line. (F) Average protein decay of the clones shown in (E): DLL4 is more stable (half-life
7.3 hours) than DLL1 (half-life 4.9 hours). Dashed lines indicate the 95% confidence interval.
(TIF)
S6 Fig. Influence of the presence of LFNG or JAG1 or of inhibition of N-glycosylation on
Notch activation. (A) Notch trans-activation assays with co-cultures of CHOattP (negative
control), CHOattP-DLL1 and CHOattP-DLL4 cells with Notch reporter expressing HeLa-N1 cells
(cf. Fig 5D) without and with transient expression of LFNG-HA. Expression of LFNG in HeLa-
N1 cells decreases the trans-activation ability of DLL4 to levels similar to DLL1, whose activa-
tion potential is slightly increased. (B) Scheme of interactions in co-cultivation assays with pos-
sible influence of LFNG expressed in HeLa-N1 cells. (C)Western blot showing the expression
of LFNG-HA in HeLa-N1 cells used in (A); β-tubulin, loading control. (D)Notch trans-activa-
tion assays with CHOattP, CHOattP-DLL1-Flag and CHOattP-DLL4-HA cells without or with stable
expression of JAG1-Myc (S4C and S4D Fig) in co-culture with Notch reporter expressing
HeLa-N1 cells. Stable coexpression of JAG1 in DLL1 or DLL4 presenting cells does not signifi-
cantly change Notch activation. DLL4 plus JAG1 activate the receptor more efficiently than
DLL1 plus JAG1. (E) Scheme of different possible interactions in co-cultivation assays with or
without stable JAG1 expression. (F)Western blot showing the expression of DLL1-Flag,
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DLL4-HA and JAG1-Myc used in (D). β-actin, loading control. (G) Notch trans-activation
assay with co-cultures of CHOattP, CHOattP-DLL1-Flag and CHOattP-DLL4-Flag cells with Notch
reporter expressing HeLa-N1 cells in the absence or presence of tunicamycin, an inhibitor of
N-linked glycosylation. Cultivation in the presence of 1 μg/ml tunicamycin (dissolved in
DMSO) decreases the activating potential of both DLL1 and DLL4 to similar levels. (H) Treat-
ment with 1 μg/ml tunicamycin results in a size shift of DLL1 and DLL4 (asterisks) indicating
an efficient block of N-glycosylation. DLL1 and DLL4 contain one and five N-glycosylation
sites, respectively; consistently, the shift is stronger for DLL4. Error bars represent SEM; ns, not
significant; , P<0.05; , P<0.01, ,P<0.001.
(TIF)
S7 Fig. DLL1 and DLL4 transiently expressed in HeLa-N1 cells: Interactions, expression
and robustness of cis-inhibition assay. (A) Schema of all different cell interactions possible in
co-cultivation assays with untransfected and transfected HeLa-N1 cells, CHOattP cells and
CHOattP-DLL1 cells shown in Fig 5Ea (left) and 5Eb (right). (B,C) Transient expression of
ligands was tested by Western blot analysis with anti-Flag antibodies (DLL1 and DLL4 labelled
with asterisks). As expected, transient expression levels vary; in some experiments (exp 1–3; B),
DLL4 was expressed more strongly than DLL1, while in other experiments (exp 4–6; C) DLL1
was expressed more strongly than DLL4. Cells of all six transfections shown were used in
Notch activation assays shown in Fig 5E (n = 6). Separate analyses of Notch activation assays
performed with cells that express either (D) DLL4 (B; n = 3) or (E) DLL1 (C; n = 3) more
strongly result in diagrams very similar to Fig 5E, demonstrating that Notch activation assays
were robust and independent of transient expression levels; a’,b’,c’ in (D,E) refer to a,b,c in
Fig 5E. Error bars represent SEM; ns, not significant; , P<0.05; , P<0.01; , P<0.001; ,
P<0.0001.
(TIF)
S8 Fig. Expression of NOTCH1 in transiently transfected CHOattP cells. Lysates of
CHOattP-DLL1 or CHOattP-DLL4 cells transiently transfected with Notch1-Flag (N1ΔC) were ana-
lysed on a Western blot with anti-Flag antibodies. All transfected cell populations (used in Fig
5F) express NOTCH1. CHO, negative control; β-actin, loading control.
(TIF)
S9 Fig. Chimeric DLL1-DLL4 proteins transiently expressed in HeLa-N1 cells: Expression,
surface localisation and trans-activation efficiency. (A) Expression of chimeric ligands in
transiently transfected HeLa-N1 cells was checked by Western blot analysis with anti-Flag
antibodies. Lysates of cells from all transfections (exp 1–6) used in Fig 5G are shown, DLL4-
DLL1ECD and DLL4-DLL1ECD signals indicated with asterisks; HeLa-N1, untransfected neg-
ative control; Flag background signal or β-tubulin, loading control. (B) Immunofluorescence of
CHOattP cells stably expressing Flag-tagged chimeric ligands with anti-Flag antibodies (Alex-
a488-conjugated secondary antibody, green; nuclei stained with TO-PRO3, blue) shows cell
surface localisation of both. (C) Surface biotinylation assays of chimeric proteins stably
expressed in CHOattP cells indicate higher cell surface levels of DLL4-DLL1ECD than of
DLL1-DLL4ECD; , P<0.05. (D)Notch trans-activation assays with CHOattP cells, cells stably
expressing non-chimeric proteins (CHOattP-DLL1-Flag, CHOattP-DLL4-HA) and cells expressing
chimeric proteins (CHOattP-DLL1-DLL4ECD-Flag and CHOattP-DLL4-DLL1ECD-HA cells) co-cultured
with Notch-reporter containing HeLa-N1 cells. The results show that all ligands, non-chimeric
or chimeric, activate Notch; DLL4 and DLL4-DLL1ECD are slightly more efficient activators
in this assay. Error bars represent SEM; ns, not significant; , P<0.01.
(TIF)
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S1 Table. Raw data of GFP protein level analysis in Fig 1C. In two independent experiments
six E8.5 embryos of each genotype were lysed in 2x sample buffer and analysed by Western
blot using anti-GFP and anti-β-actin antibodies. The signals were quantified using ImageJ soft-
ware. The GFP signals were divided by β-actin for normalisation of different amounts loaded;
additionally, the values of each experiments were divided by the CAG:Dll1 value for normalisa-
tion.
(PDF)
S2 Table. Raw data of DLL1-HA and DLL4-HA protein level analysis in Fig 1D. In three
independent experiments, confluent embryonic stem cells on 6 cm dishes were lysed in sample
buffer and analysed on Western blots using anti-HA- and anti-β-tubulin antibodies. Three
embryonic stem cell clones expressing DLL1-HA and DLL4-HA from the recombined Hprt
locus were analysed; every lysate was loaded twice (#WB). HA and β-tubulin signals were
quantified using ImageJ software. HA signals were divided by β-tubulin signals (normalisation
of different amounts loaded) and the average value of every clone in every experiment was cal-
culated and analysed using Prism software (GraphPad).
(PDF)
S3 Table. Raw data of DLL1-Flag and DLL4-Flag protein level analysis in Fig 5B. Cells were
plated on 6 cm dishes, cultured over night, lysed and analysed on Western blots with anti-Flag
and anti-β-tubulin antibodies in four independent experiments. Each cell lysate was loaded
twice (#WB). Two clones of each cell line were tested. Flag and β-actin signal intensities were
determined using ImageJ. For normalisation, Flag signals were divided by ß-actin signals and
the average for every clone in every experiment was calculated. Finally, all samples were nor-
malized to clone CHOattP-DLL1 B5 to account for differences between the individual experi-
ments.
(PDF)
S4 Table. Raw data of DLL1-Flag and DLL4-Flag protein level analysis in S5B Fig. Protein
levels of additional CHOattP-DLL1 and CHOattP-DLL4 clones were analysed as described in S3
Table.
(PDF)
S5 Table. Raw data of DLL1-Flag and DLL4-Flag cell surface level analysis in Fig 5C. Lysates
from biotinylation assays were analysed on Western blots and signals were quantified using
ImageJ software. Each lysate was analysed at least twice (#WB) and the average was used as
result from the respective experiment.
(PDF)
S6 Table. Raw data of cell surface level analysis of chimeric DLL1-DLL4 proteins in S9C
Fig. Biotinylation assays were performed to determine the relative cell surface levels of the chi-
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